Growth Metrics

Biomarin Pharmaceutical (BMRN) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Biomarin Pharmaceutical (BMRN) over the last 17 years, with Q3 2025 value amounting to $978000.0.

  • Biomarin Pharmaceutical's Amortizatization of Intangibles fell 4961.36% to $978000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 4020.52%. This contributed to the annual value of $8.3 million for FY2024, which is 956.87% down from last year.
  • Biomarin Pharmaceutical's Amortizatization of Intangibles amounted to $978000.0 in Q3 2025, which was down 4961.36% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Amortizatization of Intangibles ranged from a high of $2.6 million in Q2 2023 and a low of -$1.9 million during Q4 2021
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $1.4 million (2025), whereas its average is $687894.7.
  • Per our database at Business Quant, Biomarin Pharmaceutical's Amortizatization of Intangibles crashed by 557727.27% in 2021 and then soared by 43502.24% in 2023.
  • Quarter analysis of 5 years shows Biomarin Pharmaceutical's Amortizatization of Intangibles stood at -$1.9 million in 2021, then soared by 137.21% to $698000.0 in 2022, then soared by 250.57% to $2.4 million in 2023, then decreased by 29.46% to $1.7 million in 2024, then crashed by 43.34% to $978000.0 in 2025.
  • Its Amortizatization of Intangibles stands at $978000.0 for Q3 2025, versus $1.4 million for Q2 2025 and $1.4 million for Q1 2025.